23rd Annual Medtech MVP
Tackling Medtech's Timeliest Issues and Opportunities
June 17-18, 2024, ALL TIMES CDT
The popular 23rd Annual Medtech MVP conference is an annual gathering of the leading medtech innovators, investors, and executives from around the nation. This conference features candid discussions (panels or 1-on-1 conversations) that explore relevant topics for medtech innovators and business leaders as well as ample networking in a tight community. The many years of successful Medtech MVP programming have relied on insightful and beneficial perspectives and recommendations from our various keynotes and panels. The speakers draw from their experiences to share insights that are valuable and timely. This year we will focus on timely topics, such as breakthrough devices, pitch contest, raising capital, M&A vs. IPO debate, innovation in chronic diseases, the convergence of software and hardware, clinical/regulatory strategies, a reverse-pitch panel keynote fireside chat, and an open discussion town hall. Join leading medtech experts at this boutique event as we continue to help advance the industry through thought-sharing and networking that helps drive innovation!
Tuesday, June 20
Registration Open
Patrice Kloss, Partner, Fox Rothschild LLP
Scott Brown, PhD, Chief Scientific Strategist, Bright Research Partners
Kathy Herzog, BSME, Senior Regulatory, Quality & Compliance Consultant, Duval & Associates
Jenny Fuller, Partner, Fox Rothschild
Lori Milbrandt, Retired CFO, Imricor Medical Systems
Eric S. Heinz, President, Heinz Ventures, LLC
Andrew Savarese, Vice President, Digital Surgery, Cambridge Consultants
Krishna Srikrishna, Surgical Robotics Data Analyst, Medtronic
Brian Stellmach, Vice President, Digital Solutions, Asensus Surgical, Inc.
The promise of digital surgery is an insight driven intra-operative experience that drives a higher quality of care. To achieve this, the MedTech industry has the enormous task of developing devices that can inform surgeons when they need it most. This panel will explore data in healthcare not as an asset to be solely owned but as a product and the challenges and opportunities in front of us to unlocking this product’s potential.
Brett Erickson, Dir Sales Operations, Teleflex
Manish Sharma, CEO, TikaMobile
In today's evolving healthcare industry, successful medical device companies must establish contracts with a range of account types to effectively provide patient care. To ensure access to diverse patient populations, it is essential to have agreements with IDNs, GPOs, and HCP accounts. However, managing these contracts can become inefficient and time-consuming as businesses expand. This session aims to introduce a solution that enables visibility into contract conditions and commitments, leading to improved contract performance and commercial success.
Bonus: Create effective HCP and HCO target lists using claims data to help prioritize and segment accounts.
Mike Fix, Director, Life Sciences, Guidehouse
Kevin Hykes, President and CEO, Augmedics
Matt Likens, CEO, GT Medical
Medical technology products add immense value to the healthcare system in a myriad of ways. The benefits provided by medical technologies can be categorized into two major groups - those that provide “direct benefit” (e.g., devices that directly influence clinical outcomes) and those that provide “enabling benefit” (e.g., devices that facilitate improved surgical procedures, monitor patients remotely, or diagnose conditions). This panel will discuss how market development challenges and barriers differ between these two categories and provide some key lessons learned directly from company leaders in this space.
Dan Hanson, Senior Vice President, Management Liability and Client Experience, Marsh McLennan Agency
Bjorn Honda, Executive Vice President, Management Liability Group, Marsh McLennan Agency
David Krenn, Chief Financial Officer, HistoSonics, Inc.
Bret Puls, Partner, Fox Rothschild LLP
Welcome Networking Reception
Close of Day
Wednesday, June 21
Registration and Networking Breakfast
Reducing the Cost of Care: ASC, Care in the Office, and Home Care
Sarah Worrell, CEO, Melodi Health
How do we properly incentivize clinicians and give them the tools they need to meaningfully reduce costs in healthcare? This panel explores moving care from hospitals to ASCs, clinics, or the home as a platform for meaningfully taking costs out of healthcare. Key topics include innovation in reimbursement, importance of early detection, and key therapeutic areas to prioritize for treating patients outside the hospital setting.
Janet Benton, COO, Twin Cities Orthopedics and Revo Health
Andy Doraiswamy, Founder & CEO, Koya Medical
James Eadie, MD, Managing Director, Sante Ventures
Carlton W. Weatherby, Vice President & General Manager, Spine & Biologics, Cranial & Spinal Technologies, Medtronic
Networking Coffee Break
James Eadie, Managing Director, Sante Ventures
Ryan Egeland, Chief Executive Officer, Crossfire Medical and Founding Partner & Managing Director, Big Sky Biomedical
Mark Gardner, Directing Attorney, Gardner Law, PLLC
Sarah Karlgaard, General Counsel & Secretary, FUJIFILM Holdings America Corporation
NASA defines the “Goldilocks zone” as the habitable zone around a star where liquid water can exist on the surface of surrounding planets. Like the third of the three bowls of porridge in the tale of Goldilocks and the Three Bears, this is the ”sweet spot” where it is neither too hot nor too cold, but just right for life to exist. This breakout discussion will apply the “Goldilocks zone” concept to buyers. Savvy fiduciaries strike a delicate balance during diligence to make deals that fall within a regulatory Goldilocks zone. Buyers avoid deals that are too cold, e.g., a company that lacks necessary regulatory and compliance controls. Likewise, they avoid deals that are too hot, e.g., a company that has the necessary regulatory and compliance controls in place but does not comply with them in practice. A distinguished panel will pull back the curtain on the due diligence process and supply helpful insights on how to make sure your next deal is “just right” from a regulatory diligence perspective.
Sheila Shah, Managing Director, Consulting, L.E.K. Consulting
Daniel Hawkins, Founder & CEO, Avail Medsystems Inc
David Gregory, MPA, FACHE, Principal, Baker Tilly
Real-world evidence (RWE) can help pharmaceutical and medical device companies in a variety of ways. From determining the effectiveness of a therapeutic to demonstrating the product’s economic value to helping gain coverage and acceptance from payers and providers, the opportunities are far-reaching. However, knowing when to tap into RWE and how to use it during the product development life cycle can help accelerate your therapeutic for market access success.
Join Baker Tilly for an informative webinar discussing the importance of utilizing RWE. In addition to discussing what payers and providers are looking for in order to provide coverage and utilize your therapeutic, our team will also discuss how life sciences companies can gain a better understanding of knowing the right time and place to use RWE during the product life cycle to accelerate the adoption and success of your product or device.
Adoption of Digital Technology into Medical Devices and Healthcare
Lisa Suennen, Managing Partner, Venture Valkyrie, LLC
After years of living in parallel universes, Digital Technologies and Medical Devices are finally finding themselves connected. The opportunity to integrate data into the device realm to the benefit of patients, payers and providers is significant. But a myriad of challenges make this combination of capabilities and cultures complex. The panel will discuss what has worked and what has yet to be optimized at this confluence of healthcare segments.
Aabed Meer, MD, Partner, Questa Capital
David Van Sickle, Co-founder and Chief Commercial Officer, AyrFlo
Cathy Skinner, CEO, NXGenPort
Liane Teplitsky, President, Global Robotics and Technology & Data Solutions, Zimmer Biomet
Healthcare Executive Interview
Gianrico Farrugia, MD, President and CEO, Mayo Clinic
A distributed data network platform model for healthcare solves many of the systemic problems facing healthcare, from curing disease, to improving patient access and tackling disparities, to enhancing collaboration. Dr. Gianrico Farrugia, CEO of Mayo Clinic, and Cathy Wurzer, host of Morning Edition for MPR News, discuss Mayo Clinic's platform transformation of healthcare and why Mayo Clinic is committed to "leading together" toward a better future for healthcare.
Cathy Wurzer, Host, Morning Edition, MPR News
Networking Luncheon
Medtech by the Numbers
Jonathan Norris, Managing Director, HSBC Innovation
Please join Jonathan Norris from HSBC as he dissects Q1 med device investment trends. He will cover overall healthcare investment in Q1, and will focus on med device investment (Seed/Series A and later stage) by indication, valuation and step-up. In addition, Jon will cover M&A trends over the past five years, detailing private venture-backed acquisitions by the most active strategies, as well as analysis of 510(k)/PMA trends.
Overcoming Valuation Overhang – Implications on Raising Capital and Exits
Geoffrey Pardo, General Partner, Gilde Healthcare
The bullishness that existed from 2016-2022 has given way to uncertainty and volatility. Public markets are difficult to access and acquirers have struck a more conservative approach. This panel will discuss the implications for private companies, particularly those that were financed during the boom times. Key topics will include strategies for keeping private companies financed, as well as the outlook for liquidity via M&A or IPO.
Tak G Cheung, Partner, New Enterprise Associates
J.P. Peltier, Managing Director, Global Head, Healthcare Investment Banking, Piper Sandler
Michael Ryan, VP, Venture Capital & Business Development, Boston Scientific Corp
Gwen Watanabe, Managing Director, H.I.G. Capital
Rob Winklemann, Managing Partner & CEO, Credo 180
Presentation of 2023 Medtech MVP Award
Interview with Medtech MVP 2023 Award Recipient
Erica Rogers, CEO, Silk Road Medical
Erica and Jim have known each other since 2008 when they negotiated across the table from each other. That initial series of meetings evolved into a 15-year relationship of mutual admiration. In this interview, they will talk about Erica’s career, focusing on key decisions that led her to become initially a serial entrepreneur and ultimately the leader of one of the most successful SmidCap companies of our time.
James Adox, Executive Managing Director, Venture Investors, LLC
Networking Refreshment Break
The Value of Representation in Healthtech
Ingrid Ellerbe, Executive Director, DxD Healthtech (Diversity by Doing)
Within the framework of funding, innovation, organizational structure & regulatory requirements there exists a tremendous upside in leveraging equitable representation. Innovations that aim to improve the prevention, diagnosis, and treatment of human disease often intend to have broad societal benefit, but often, they fail to benefit everyone equally and worsen health. Let’s talk about how the healthtech innovation process, and the innovations that result, be made more equitable.
Lisa Lavin, Founder, Chairman and CEO, Omcare
Juan-Pablo Mas, Partner, Action Potential VC
Sally Saba, MD, MBA, VP - Global Chief Inclusion and Diversity Officer, and President of the Medtronic Foundation
Kendal Whitlock, Head, Digital Optimization, RWE Clinical Trials, Walgreens Co.
Town Hall – YOUR Discussion of Topics that are Top-of-Mind
Stacy Enxing Seng, Venture Partner, Lightstone Ventures
Tim Herbert, President & CEO, Inspire Medical Systems, Inc.
Kirk Nielsen, Managing Partner, Vensana Capital
After a day of dialogue on issues that matter to you as investors, company builders, and corporate partners, we will no doubt have more to explore together as we navigate one of the most dynamic periods in our sector’s history. This interactive, engaging, and provocative session will cover topics that matter to you and your business. Our panel of industry veterans will share their ideas and points of view, but we really want to hear from you! So please come ready to tee up issues you’d like to discuss and be prepared to engage with your peers as we efficiently unpack a variety of topics.
Closing Networking Reception
Close of Summit